The Priority Review

Policy Brief

Genomics announces extension of strategic drug discovery collaboration with Vertex

Genomics announced a four-year extension of its eight-year drug target discovery and validation collaboration with Vertex, beginning November 18, 2026. The total potential contract value exceeds $220 million for milestone achievements and future royalties.

Primary source

Company press release (PR Newswire), November 18, 2026

Genomics Ltd. Announces Extension of Strategic Drug Discovery Collaboration with Vertex Pharmaceuticals

Read the source: Genomics Ltd. Announces Extension of Strategic Drug Discovery Collaboration with Vertex Pharmaceuticals prnewswire.com

Machine-summarized from the source above; not independently reported. How we use automation